{"article": [{"url": "https://www.marketwatch.com/story/painreform-sets-ipo-terms-with-plans-to-offer-255-million-units-priced-at-8-to-10-each-2020-08-24", "published": 1598272580.0, "headline": "PainReform sets IPO terms with plans to offer 2.55 million units priced at $8 to $10 each", "body": "PainReform Ltd. PRFX, +1.63%, an Israeli start up that is aiming to develop non-opioid post-surgery pain treatments, set terms for its initial public offering on Monday, with plans to offer 2.55 million units priced at $8 to $10 each. Each unit will consist of one ordinary share and a warrant to purchase a share, the company said in a regulatory filing. The company has applied to list on Nasdaq under the ticker \"PRFX.\" Maxim Group and Joseph Gunnar & Co. are underwriting the deal. Proceeds will be used to fund clinical trials, and for general corporate purposes. \"Our proprietary extended release drug-delivery system is designed to provide an extended period of post-surgical pain relief without the need for repeated dose administration while reducing the potential need for the use of opiates,\" the company says in its prospectus."}]}